Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

419

HTML

4196

Figures (1-3)

300

Sum=4915

Jul 28, 2006 (publication date) through Dec 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jul 28, 2006; 12(28): 4445-4451
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4445

Full Size Figure Download Figure

Figure 3 Targets for medical treatment of intrahepatic cholestasis. BA: Bile acids. For details see text.

Citation: Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World J Gastroenterol 2006; 12(28): 4445-4451
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4445.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4445